Adverse Reactions from Botulinum Toxin Administration

REFERENCES

• FDA Gives Update on Botulinum Toxin Safety Warnings; Established Names of Drugs Changed. Retrieved December 11, 2009 from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm175013.htm.
   Google Scholar
• Setler P. Therapeutic use of botulinum toxins: Background and history. Clinical Journal of Pain 2002;18(suppl 6):S119–S124.
   Google Scholar
• Setler P. The biochemistry of botulinum toxin type B. Neurology 2000:55(suppl 1):S22–S28.
   Google Scholar
• Aoki KR. Pharmacology and immunology of botulinum toxin serotypes. J Neurol 2001;248 (suppl 1):1–10.
   Google Scholar
• Misra VP. The changed image of botulinum toxin: Its unlicensed use is increasing dramatically, ahead of robust evidence. BMJ 2002:325;1188.
   Google Scholar
• Wiegand H, Erdmann G, Wellhoner HH. 125-I labelled botulinum A neurotoxin: Pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol. 1976;292:161–165.
   PubMed Web of Science ®Google Scholar
• Habermann E. I-125 labeled neurotoxin from Clostridium botulinum A: Preparation, binding to synaptosomes and ascent to the spinal cord. Naunyn Schmiedebergs Arch Pharmacol 1974;281:47–56.
   Google Scholar
• Costantin L, Bozzi Y, Richichi C, Viegi A, Antonucci F, Funicello M, Gobbi M, Mennini T, Rossetto O, Montecucco C, Maffei L, Vezzani A, Caleo M. Antiepileptic effects of botulinum neurotoxin E. J Neurosci. 2005;25(8):1943–1951.
   Google Scholar
• Bozzi Y, Costantin L, Antonucci F, Caleo M. Action of the botulinum neurotoxins in the central nervous system: Antiepileptic effects. Neurotox Res. 2006;9(2–3):197–203.
   Google Scholar
• Wohlfarth K, Schubert M, Rothe B, Elek J, Dengler R. Remote F-wave changes after local botulinum toxin application. Clin Neurophysiol. 2001;112:636–640.
   PubMed Web of Science ®Google Scholar
• Priori A, Berardelli A, Mercuri B, Manfredi M. Physiological effects produced by botulinum toxin: Changes in reciprocal inhibition between forearm muscles. Brain. 1995;118(3):801–807.
   Google Scholar
• Grandas F, Traba A, Alonso F, Esteban A. Blink reflex recovery cycle in patients with blepharospasm unilaterally treated with botulinum toxin. Clin Neuropharmacol. 1998;21:307–311.
   Google Scholar
• Gilio F, Currà A, Lorenzano C, Modugno N, Manfredi M, Berardelli A. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol. 2000;48(1):20–26.
   Google Scholar
• Sahai A. A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int 2006;97(2):413.
   Google Scholar
• Shaban AM, Drake MJ. Botulinum toxin treatment for overactive bladder: Risk of urinary retention. Curr Urol Rep. 2008;9(6):445–451.
   Google Scholar
• De Laet K, Wyndaele JJ. Adverse events after botulinum A toxin injection for neurogenic voiding disorders. Spinal Cord 2005;43(7):397–399.
   Web of Science ®Google Scholar
• Wyndaele JJ, Van Dromme SA. Muscular weakness as a side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 2002;40(11):599–600.
   Google Scholar
• Comella CL, Tanner CM, DeFoor-Hill L, Smith C. Dysphagia after botulinum toxin injections for spasmodic torticollis: Clinical and radiologic findings. Neurology. 1992;42(7):1307–1310.
   Google Scholar
• Buchholz DW, Neumann S. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia. Dysphagia 1997;12(1):59–60.
   Google Scholar
• Kowing D. Madarosis and facial alopecia presumed secondary to botulinum A toxin injections. Optom Vis Sci 2005;82(7):579–582.
   Google Scholar
• LeWitt PA, Trosch RM. Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection. Mov Disord 1997;12(6):1064–1067.
   Google Scholar
• Bakheit AM, Ward CD, McLellan DL. Generalized botulism-like syndrome after intramuscular injections of botulinum toxin type A: A report of two cases. J Neurol Neurosurg Psych 1997;62(2):198.
   Google Scholar
• Sheean GL, Murray NM, Marsden CD. Pain and remote weakness in limbs injected with botulinum toxin A for writer’s cramp. Lancet 1995;346(8968):154–156.
   Google Scholar
• Lange DJ, Brin MF, Warner CL, Fahn S, Lovelace RE Distant effects of local injection of botulinum toxin. Muscle Nerve 1987;10(6):552–525.
   Google Scholar
• Thobois S, Broussolle E, Toureille L, Vial C. Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy. Mov Disord. 2001;16(4):764–765.
   Google Scholar
• Sławek J, Madaliński MH, Maciag-Tymecka I, Duzyński W. Frequency of adverse effects after botulinum toxin injections in neurology, rehabilitation and gastroenterology. Pol Merkur Lekarski. 2005;18(105):298–302.
   Google Scholar
• Borodic GE, Joseph M, Fay L, Cozzolino D, Ferrante RJ. Botulinum A toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxic spread. Head Neck. 1990;12(5):392–399.
   Google Scholar
• Tintner R, Gross R, Winzer UF, Smalky KA, Jankovic J. Autonomic function after botulinum toxin type A or B: A double blind, randomized trial. Neurology. 2005;65(5):765–767.
   Google Scholar
• Factor SA, Molho ES, Evans S, Feustel PJ. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia. Mov Disord. 2005;20(9):1152–1160.
   Google Scholar
• Dressler D, Benecke R. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol 2003;49(1):34–38(18).
   Google Scholar
• Anderson TJ, Rivest J, Stell R, Steiger MJ, Cohen H, Thompson PD, Marsden CD. Botulinum toxin treatment of spasmodic torticollis. R Soc Med. 1992;85:524–529.
   Google Scholar
• Defazio G, Lepore V, Melpignano C, Lamberti P, Livrea P, Ferrari E. Cervical radiculopathy following botulinum toxin therapy for cervical dystonia. Funct Neurol. 1993;8(3):193–196.
   Google Scholar
• Burbaud P, Wiart L, Dubos JL, Gaujard E, Debelleix X, Joseph PA, Mazaux JM, Bioulac B, Barat M, Lagueny A. A randomized, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psych. 1994;57:1320.
   Google Scholar
• Garner CG, Straube A, Witt TN, Gasser T, Oertel H. Time course of distant effects of local injections of botulinum toxin. Mov Disord. 1993;8(1):33–37.
   Google Scholar
• Ansved T, Odergren T, Borg K. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment for cervical dystonia. Neurology 1997;48(5):1440–1442.
   Google Scholar
• Racette BA, Lopate G, Good L, Sagitto S, Perlmutter JS. Ptosis as a remote effect of therapeutic botulinum toxin B injection. Neurology. 2002;59(9):1445–1447.
   Google Scholar
• Tarsy D. Polyradiculoneuritis after botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol 2001;24(2):122–123.
   Google Scholar
• Burguera JA, Villaroya T, López-Alemany M. Polyradiculoneuritis after botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol 2000;23(4):226–228.
   Google Scholar
• Tarsy D. Brachial plexus neuropathy after botulinum toxin injection. Neurology 1997;49(4):1176–1177.
   Google Scholar
• Onoue H, Matsunobu A, Nagaishi A, Yukitake M, Kuroda Y. A case report of acute Polyradiculoneuritis developing after multiple injections of botulinum toxin for cervical dystonia. Rinsho Shinkeigaku. 2004;44(1):20–24.
   Google Scholar
• Bhatia KP, Münchau A, Thompson PD, Houser M, Chauhan VS, Hutchinson M, Shapira AH, Marsden CD. Generalized muscle weakness after botulinum toxin injection for dystonia: A report of three cases. J Neurol Neurosurg Psychiatry. 1999;67(1):90–93.
   Google Scholar
• Sampaio C, Castro-Caldas A, Sales-Luis MI, Alves M, Pinto L, Apolinario P. Brachial plexopathy after botulinum toxin administration for cervical dystonia. J Neurol Neurosurg Psych. 1993;56:220.
   Google Scholar
• Lange DJ, Rubin M, Greene PE, Kang UJ, Moskowitz CB, Brin MF, Lovelace RE, Fahn S. Distant effects of locally injected botulinum toxin: A double blind study of single fiber electromyography. Muscle Nerve. 1991;14:672–675.
   PubMed Web of Science ®Google Scholar
• Cobb DB, Watson WA, Fernandez MC. Botulism like syndrome after injections of botulinum toxin. Vet Hum Toxicol 2000;42(3):163.
   Google Scholar
• Rossi RP, Strax TE, Di Rocco A. Severe dysphagia after botulinum toxin B injection to the lower limbs and lumbar paraspinal muscles. Am J Phys Med Rehabil 2006;85(12):1011–1013.
   Google Scholar
• Partikian A, Mitchell WG. Iatrogenic Botulism in a child with spastic quadriparesis. J Child Neurol 2007;22(10):1235–1237.
   Google Scholar
• Crowner BE, Brunstrom JE, Racette BA. Iatrogenic botulism due to therapeutic botulinum toxin injection in a pediatric patient. Clin Neuropharmacol 2007;30(5):310–313.
   Google Scholar
• Roche N, Schnitzler A, Genêt F F, Durand MC, Bensmail D. Undesirable distant effects following botulinum toxin type A injection. Clin Neuropharmacol 2008;31(5):272–280.
   Google Scholar
• Turkel CC, Bowen B, Liu J, Brin MF. Pooled analysis on the safety of botulinum toxin type A in the treatment of post stroke spasticity. Arch Phys Med Rehabil. 2006;87(6):786–792.
   Google Scholar
• Papadonikolakis AS, Vekris MD, Kostas JP, Korompilias AV, Soucacos PN. Transient erectile dysfunction associated with intramuscular injection of botulinum toxin type A. J South Orthop Assoc. 2002;11(2):116–118.
   Google Scholar
• Omoigui S, Irene S. Treatment of ptosis as a complication of botulinum toxin injection. Pain Med 2005;6(2):149–151.
   Google Scholar
• Gioltzoglou T, Cordivari C, Lee PJ, Hanna MG, Lees AJ. Problems with botulinum toxin treatment in mitochondrial cytopathy: Case report and review of the literature. J Neurol Neurosurg Psychiatry. 2005;76(11):1594–1596.
   Google Scholar
• Abbott Z, Richardson JK. Subacromial impingement syndrome as a consequence of botulinum therapy to the upper trapezii: A case report. Arch Phys Med Rehabil 2007;88(7):947–949.
   Google Scholar
• Li M, Goldberger BA, Hopkins C. Fatal case of BOTOX-related anaphylaxis? J Forensic Sci 2005;50(1):169–172.
   Google Scholar
• Bakheit AM. The possible adverse effects of intramuscular botulinum toxin injections and their management. Curr Drug Saf 2006;1(3):271–279.
   Google Scholar
• Gioltzoglou T, Cordivari C, Lee PJ, Hanna MG, Lees AJ. Problems with botulinum toxin treatment in mitochondrial cytopathy: Case report and review of the literature. J Neurol Neurosurg Psychiatry. 2005;76(11):1594–1596.
   Google Scholar
• Meichsner M, Reichel G. Effect of botulinum toxin A and B on vegetative cardiac innervations. Fortschr Neurol Psychiatr 2005;73(7):409–414.
   Google Scholar
• Mac Iver R, Liptay M, Johnson Y. A case of mediastinitis following botulinum toxin type A treatment for achalasia. Nat Clin Pract Gastroenterol Hepatol 2007;4(10):579–582.
   Google Scholar
• Eaker EY, Gordon JM, Vogel SB. Untoward effects of esophageal botulinum toxin injection in the treatment for achalasia. Dig Dis Sci 1997;42(4):724–727.
   Google Scholar
• Malnick SD, Metchnik L, Somin M, Bergman N, Attali M. Fatal heart block following treatment with botulinum toxin for achalasia. Am J Gastroenterol. 2000;95(11):3333–3334.
   Google Scholar
• Khurana V, Nehme O, Khurana R, Barkin JS. Urinary retention secondary to detrusor muscle hypofunction after botulinum toxin injection for achalasia. Am J Gastoenterol. 2001;96(11):3211–3212.
   Google Scholar
• Madaliński MH, Sławek J, Duzyński W, Zbytek B, Jagiełło K, Adrich Z, Kryszewski A. Side effects of botulinum toxin injection for benign anal disorders. Eur J Gastroenterol Hepatol. 2002;14(8):853–856.
   Google Scholar
• Tan EK, Lo YL, Seah A, Auchus AP. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhea in amyotrophic lateral sclerosis. J Neurol Sci. 2001;190(1–2):95–97.
   Google Scholar
• Swartling C, Färnstrand C, Abt G, Stålberg E, Naver H. Side-effects of intradermal injections of botulinum A toxin in the treatment of palmar hyperhidrosis: A neurophysiological study. Eur J Neurol. 2001;8(5):451–456.
   Google Scholar
• Tejedor J, Rodriguez JM. Early retreatment of infantile esotropia: Comparison of reoperation and botulinum toxin. Ophthalmology 1986;93:1621–1627.
   Google Scholar
• Lennerstrand G, Nordbo OA, Tian S, Eriksson-Derovet B, Ali T. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand. 1988;76(1):27.
   Google Scholar
• Wutthiphan S, Kowal L, O’Day J, Jones S, Price J. Diplopia following subcutaneous of botulinum toxin A for facial spasms. J Pediatr Ophthalmol Strabismus. 1997;34:229–234.
   PubMed Web of Science ®Google Scholar
• Hemmerdinger C, Srinivasan S, Marsh IB. Reversible papillary dilation following botulinum toxin injection to lateral rectus. Eye. 2006;20(12):1478–1479.
   Google Scholar
• Mohan M, Tow S, Fleck BW, Lee JP. Permanent extraocular muscle damage following botulinum toxin injection. Br J Ophthalmol. 1999;83(11):1309–1310.
   Google Scholar
• Bowden JB, Rapini RP. Psoriasiform eruption from intramuscular botulinum A toxin. Cutis. 1992;50(6):415–416.
   Google Scholar
• Moguel-Ancheita S, Orozco-Gómez LP, Gallego-Duarte M, Alvarado I, Montes C. Metabolic changes in brain cortex related with strabismus treatment. Preliminary results with SPECT. Cir. 2004;72(3):165–170.
   Google Scholar
• Verhulst S, Smet H, De Wilde F, Tassignon MJ. Levator aponeurosis dehiscence in a patient treated with botulinum toxin for blepharospasm and eyelid apraxia. Bull Soc Belge Ophtalmol. 1994;252:51–53.
   Google Scholar
• Burns CL, Gammon JA, Gemmill MC. Ptosis associated with botulinum toxin treatment for strabismus and blepharospasm. Ophthalmology 1986;93(12):1621–1627.
   Google Scholar
• Price J, O’Day J. Efficacy and side effects of botulinum toxin for treatment of blepharospasm and hemifacial spasm. Aust N Z J Ophthalmol. 1994;22(4):255–260.
   Google Scholar
• Erbguth F, Claus A, Engelhardt A, Dressler D. Systemic effect of local botulinum toxin injections unmasks subclinical Lambert–Eaton myasthenic syndrome. J Neurol Neurosurg Psych. 1993;56;1235–1236.
   PubMed Web of Science ®Google Scholar
• Anonymous. Acute angle closure glaucoma following botulinum toxin [comment]. Br J Ophthalmol 1991;75(6):383.
   Google Scholar
• Kwek AB, Tan EK, Luman W. Dysphagia as a side effect of botulinum toxin injection. Med J Malaysia 2004;59(4):544–546.
   Google Scholar
• Iwase T, Iwase C. Systemic effect of local and small-dose botulinum injection to unmask myasthenia gravis. Graefes Arch Clin Exp Ophthalmol 2006;244(3):415–416.
   Google Scholar
• Kárpáti S, Désaknai S, Désaknai M, Bíró J, Nagy K, Horváth A. Human herpes virus 8 positive facial angiosarcoma developing at the site of botulinum toxin injection for blepharospasm. Br J Dermatol. 2000;143(3):660–662.
   Google Scholar
• Latimer PR, Hodgkins PR, Vakalis AN, Butler RE, Evans AR, Zaki GA. Necrotizing fasciitis as a complication of botulinum toxin injection. Eye. 1998;12 (Pt 1):51–53.
   Google Scholar
• Kalra HK, Magoon EH. Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm. Ophthalmic Surg 1990;21:335–338.
   PubMedGoogle Scholar
• Haug BA, Dressler D, Prange HW. Polyradiculoneuritis following botulinum therapy. J Neurol 1990;237(1):62–63.
   Google Scholar
• Ellis MF, Daniell M. An evaluation of the safety and efficacy of botulinum toxin A (BOTOX®) when used to produce a protective ptosis. Clin Experiment Ophthalmol 2001;29(6):394–399.
   Google Scholar
• Heyworth PL, Lee JP. Persisting hypotropia following protective ptosis induced by botulinum neurotoxin. Eye 1994;8( Pt 5):511–515.
   Google Scholar
• Jitpimolmard, Tiamkao, Laopaiboon. Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: A report of 175 cases. J Neurol Neurosurg Psychiatry 1998;64(6):751–757.
   Google Scholar
• Pérez-Saldaña MT, Boscá-Blasco ME, López-Poma JC, España-Gregori E, Gallego-Pinazo R, Roda-Marzal V, Roda-Cámara V, Burguera-Hernández JA. Ocular dryness in the side that was infiltrated and not infiltrated with botulinum toxin to treat hemifacial spasm. Rev Neurol. 2008;47(12):668–689.
   Google Scholar